Impact
BioMedical SIG #6
Thomas Hanke (Evotec) shares his perspective on how to strategically plan and execute preclinical validation for translational academic research. Drawing on his experience at Evotec—a leading biotechnology company specialising in collaborative drug discovery—Hanke highlights best practices to align early-stage research with potential clinical applications.